Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | -19.09% |
| Q2 2025 | 7.96% |
| Q1 2025 | -29.12% |
| Q4 2024 | 29.78% |
| Q3 2024 | -37.37% |
| Q2 2024 | -21.14% |
| Q1 2024 | 8.44% |
| Q4 2023 | 1.86% |
| Q3 2023 | 2.06% |
| Q2 2023 | 19.21% |
| Q1 2023 | -17.97% |
| Q4 2022 | 48.65% |
| Q3 2022 | -25.28% |
| Q2 2022 | 23.33% |
| Q1 2022 | -47.55% |
| Q4 2021 | -1.57% |
| Q3 2021 | -9.87% |
| Q2 2021 | 4.33% |
| Q1 2021 | -6.70% |
| Q4 2020 | -479.27% |
| Q3 2020 | 37.56% |
| Q2 2020 | -128.97% |
| Q1 2020 | 72.23% |
| Q4 2019 | -110.31% |
| Q3 2019 | 50.43% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |